Aimei Health Technology Co., Ltd - Ordinary Share

Leadership is SPAC‑oriented rather than operator‑oriented. The CEO, Junheng Xie, and CFO, Heung Ming Wong, oversee the vehicle, with the CFO holding multiple micro‑cap directorships according to the 10‑K.

Governance risk is accentuated by late filings that triggered Nasdaq deficiency notices and by China‑related disclosures indicating potential PRC regulatory processes for certain targets. There is no demonstrated track record here of acquiring and operating a high‑quality business that compounds free cash flow per share over time.